Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis

被引：0
|
作者：
J. Iwamoto
K. Makita
Y. Sato
T. Takeda
H. Matsumoto
机构：
[1] Keio University School of Medicine,Institute for Integrated Sports Medicine
[2] Keiyu Orthopaedic Hospital,Department of Orthopaedic Surgery
[3] Keio University School of Medicine,Department of Obstetrics and Gynecology
[4] Mitate Hospital,Department of Neurology
来源：
Osteoporosis International | 2011年 / 22卷
关键词：
Alendronate; Back pain; Elcatonin; Osteoporosis; Postmenopausal women;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2735 / 2742
页数：7
相关论文
共 50 条
  • [31] Effects of alendronate sodium therapy on carotid intima media thickness in postmenopausal women with osteoporosis
    Tuncay Delibasi
    Rifat Emral
    Murat F. Erdogan
    Nuri Kamel
    Advances in Therapy, 2007, 24 : 319 - 325
  • [32] Effects of alendronate sodium therapy on carotid intima media thickness in postmenopausal women with osteoporosis
    Delibasi, Tuncay
    Emral, Rifat
    Erdogan, Murat F.
    Kamel, Nuri
    ADVANCES IN THERAPY, 2007, 24 (02) : 319 - 325
  • [33] LRP5 polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis
    Zhou, Pei Ran
    Liu, Hai Juan
    Liao, Er Yuan
    Zhang, Zhen Lin
    Chen, De Cai
    Liu, Jian
    Wu, Wen
    Xing, Xiao Ping
    Xia, Wei Bo
    Xu, Ling
    Li, Mei
    PHARMACOGENOMICS, 2014, 15 (06) : 821 - 831
  • [34] Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
    Boskey, A. L.
    Spevak, L.
    Weinstein, R. S.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (05) : 793 - 800
  • [35] Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
    A. L. Boskey
    L. Spevak
    R. S. Weinstein
    Osteoporosis International, 2009, 20 : 793 - 800
  • [36] Comparative effectiveness of denosumab vs alendronate among postmenopausal women with osteoporosis
    Curtis, Jeffrey R.
    Arora, Tarun
    Liu, Ye
    Lin, Tzu-Chieh
    Spangler, Leslie
    Brunetti, Vanessa C.
    Stad, Robert Kees
    Mcdermott, Michele
    Bradbury, Brian D.
    Kim, Min
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (07) : 826 - 834
  • [37] SOST polymorphisms and response to alendronate treatment in postmenopausal Chinese women with osteoporosis
    Zhou, Pei-ran
    Xu, Xiao-jie
    Zhang, Zhen-lin
    Liao, Er-yuan
    Chen, De-cai
    Liu, Jian
    Wu, Wen
    Jiang, Yan
    Wang, Ou
    Xia, Wei-bo
    Xing, Xiao-ping
    Xu, Ling
    Li, Mei
    PHARMACOGENOMICS, 2015, 16 (10) : 1077 - 1087
  • [38] Quality of life of postmenopausal women with teriparatide, denosumab and alendronate: One-year prospective study with a propensity score-matched comparison
    Lam, Pun Yuet
    Cheung, Prudence Wing Hang
    Lau, Sin Ting
    Cheung, Jason Pui Yin
    JOURNAL OF ORTHOPAEDICS TRAUMA AND REHABILITATION, 2023, 30 (01)
  • [39] Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in China
    Li Ying
    Xuan Miao
    Wang Bo
    Yang Jun
    Zhang Hong
    Zhang Xiu-zhen
    Guo Xiao-hui
    Lu Xiao-feng
    Xue Qing-yun
    Yang Gang-yi
    Ji Qiu-he
    Liu Zhi-min
    Li Cheng-jiang
    Wu Tian-feng
    Sheng Zheng-yan
    Li Peng-qiu
    Tong Jiu-cui
    CHINESE MEDICAL JOURNAL, 2013, 126 (03) : 457 - 463
  • [40] Efficacy and safety of elcatonin in postmenopausal women with osteoporosis: a systematic review with network meta-analysis of randomized clinical trials
    Chen, W-C
    Lin, E-Y
    Kang, Y-N
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (09) : 1723 - 1732
12345